287 related articles for article (PubMed ID: 22997138)
1. Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity.
Heuts DP; Weissenborn MJ; Olkhov RV; Shaw AM; Gummadova J; Levy C; Scrutton NS
Chembiochem; 2012 Nov; 13(16):2384-91. PubMed ID: 22997138
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling.
Knapp K; Zebisch M; Pippel J; El-Tayeb A; Müller CE; Sträter N
Structure; 2012 Dec; 20(12):2161-73. PubMed ID: 23142347
[TBL] [Abstract][Full Text] [Related]
3. Giardia duodenalis: biochemical characterization of an ecto-5'-nucleotidase activity.
Russo-Abrahão T; Cosentino-Gomes D; Daflon-Yunes N; Meyer-Fernandes JR
Exp Parasitol; 2011 Jan; 127(1):66-71. PubMed ID: 20599434
[TBL] [Abstract][Full Text] [Related]
4. Active and regulatory sites of cytosolic 5'-nucleotidase.
Pesi R; Allegrini S; Careddu MG; Filoni DN; Camici M; Tozzi MG
FEBS J; 2010 Dec; 277(23):4863-72. PubMed ID: 21029378
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray analysis of the open form of human ecto-5'-nucleotidase (CD73).
Knapp KM; Zebisch M; Sträter N
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Dec; 68(Pt 12):1545-9. PubMed ID: 23192044
[TBL] [Abstract][Full Text] [Related]
6. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
7. E. coli 5'-nucleotidase undergoes a hinge-bending domain rotation resembling a ball-and-socket motion.
Knöfel T; Sträter N
J Mol Biol; 2001 May; 309(1):255-66. PubMed ID: 11491294
[TBL] [Abstract][Full Text] [Related]
8. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
[TBL] [Abstract][Full Text] [Related]
9. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
[TBL] [Abstract][Full Text] [Related]
10. X-ray structure of the Escherichia coli periplasmic 5'-nucleotidase containing a dimetal catalytic site.
Knöfel T; Sträter N
Nat Struct Biol; 1999 May; 6(5):448-53. PubMed ID: 10331872
[TBL] [Abstract][Full Text] [Related]
11. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
[TBL] [Abstract][Full Text] [Related]
12. CD73 (ecto-5'-nucleotidase) on blood mononuclear cells. Regulation of ecto-5'-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency.
Christensen LD
APMIS Suppl; 1997; 73():1-28. PubMed ID: 9393563
[No Abstract] [Full Text] [Related]
13. Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells.
Sadej R; Skladanowski AC
Acta Biochim Pol; 2012; 59(4):647-52. PubMed ID: 23162807
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and structural characterization of an alternatively spliced variant of human mitochondrial 5'(3')-deoxyribonucleotidase.
Pachl P; Fábry M; Veverka V; Brynda J; Řezáčová P
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):63-8. PubMed ID: 24506201
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
Morello S; Capone M; Sorrentino C; Giannarelli D; Madonna G; Mallardo D; Grimaldi AM; Pinto A; Ascierto PA
J Transl Med; 2017 Dec; 15(1):244. PubMed ID: 29202855
[TBL] [Abstract][Full Text] [Related]
16. A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms.
Stefano JE; Lord DM; Zhou Y; Jaworski J; Hopke J; Travaline T; Zhang N; Wong K; Lennon A; He T; Bric-Furlong E; Cherrie C; Magnay T; Remy E; Brondyk W; Qiu H; Radošević K
J Biol Chem; 2020 Dec; 295(52):18379-18389. PubMed ID: 33122192
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the pyrimidine 5'-nucleotidase SDT1 from Saccharomyces cerevisiae complexed with uridine 5'-monophosphate provides further insight into ligand binding.
Shi N; Zhang YJ; Chen HK; Gao Y; Teng M; Niu L
Proteins; 2011 Apr; 79(4):1358-62. PubMed ID: 21268116
[No Abstract] [Full Text] [Related]
18. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line.
Andrade CM; Lopez PL; Noronha BT; Wink MR; Borojevic R; Margis R; Lenz G; Battastini AM; Guma FC
Cell Tissue Res; 2011 May; 344(2):279-86. PubMed ID: 21424267
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
